Conceptualization of a Parasympathetic Endocrine System

Area of Science:

• Neuroendocrinology
• Gastroenterology

Background:

• Gut peptides like somatostatin, CCK, GLP-1, and VIP have known digestive roles.
• Their broader systemic effects and coordination via the parasympathetic nervous system are less understood.
• Previous work has partially considered gut peptides as an endocrine system, but not its parasympathetic coordination.

Purpose of the Study:

• To formalize the concept of a parasympathetic endocrine system (PES).
• To propose the dorsal motor nucleus of the vagus (DMV) as the integrative controller of the PES.
• To explore the PES's role in broadly increasing parasympathetic signaling and antagonizing sympathetic activity.

Main Methods:

• Review of anatomical substrates supporting PES.
• Examination of physiological control mechanisms.
• Analysis of existing literature on gut peptide actions and vagal modulation.

Main Results:

• Gut peptides, modulated by the dorsal motor nucleus of the vagus (DMV), form a parasympathetic endocrine system (PES).
• These peptides exert widespread effects beyond satiety, increasing systemic parasympathetic signaling.
• Evidence suggests PES antagonizes sympathetic signaling in mammals.

Conclusions:

• The PES, controlled by the DMV, represents a novel framework for understanding gut-brain-body communication.
• This concept reframes the pathophysiology of metabolic syndrome and other diseases.
• Highlights the critical role of the autonomic nervous system in health and disease.